Role of markErs in the progreSsion of dIabeteS in Obese paTIeNts

Role of Some Markers in the Progression of Diabetes in Obese Patients: a 8-year Observational Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02934737

Acronym

RESISTIN

Enrollment

1000

Registered

2016-10-17

Start date

2016-10-31

Completion date

2018-11-30

Last updated

2020-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese Patients

Keywords

Obesity, Diabetes Mellitus

Brief summary

Obese patients will be enrolled from 2006 to 2014. The progression of diabetes mellitus will be observed (if any). Anthropometric and biochemical parameters will be evaluated.

Interventions

OTHERProgression of diabetes

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Obesity (body mass index \>/= 30 Kg/m2 * Normal blood glucose (glycemia \< 100 mg/dl)

Exclusion criteria

* No

Design outcomes

Primary

Measure	Time frame	Description
Progression of diabetes	8 years	evaluation of glycemia during 8 years
Anthropometric parameters	8 years	Weight
Markers of progression of diabetes	8 years	Adiponectin

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026